Obesity and future prostate cancer risk among menafter an initial benign biopsy of the prostate

Cancer Epidemiology Biomarkers and Prevention

Volumn 22, Issue 5, 2013, Pages 898-904

  Rundle, Andrew ^a   Jankowski, Michelle ^b   Kryvenko, Oleksandr N ^c   Tang, Deliang ^a   Rybicki, Benjamin A ^b  

^a Columbia University ^*  (United States)

^b Departments of Public Health Sciences   (United States)

^c HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; CANCER FAMILY; CANCER GRADING; CANCER INCIDENCE; CANCER RISK; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DIGITAL RECTAL EXAMINATION; DISEASE DURATION; FAMILY HISTORY; FOLLOW UP; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OBESITY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATIC INTRAEPITHELIAL NEOPLASIA; RACE; TRANSURETHRAL RESECTION;

AGED; BIOPSY; BODY MASS INDEX; CASE-CONTROL STUDIES; COHORT STUDIES; HUMANS; MALE; MICHIGAN; MIDDLE AGED; NEOPLASM GRADING; OBESITY; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; SEER PROGRAM;

EID: 84877967550     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-12-0965     Document Type: Article

References (39)

1. Amercian Cancer Society. Cancer facts And figures 2012. Atlanta, GA: American Cancer Society; 2012.
2. Bostwick DG, Burke HB, Djakiew D, Euling S, Ho SM, Landolph J, et al. Human prostate cancer risk factors. Cancer 2004;101:2371-490.
3. Gronberg H. Prostate cancer epidemiology. Lancet 2003;361:859-64.
4. Hsing AW, Devesa SS. Trends and patterns of prostate cancer: What do they suggest? Epidemiol Rev 2001;23:3-13.
5. Potosky AL, Miller BA, Albertsen PC, Kramer BS. The role of increasing detection in the rising incidence of prostate cancer. JAMA 1995;273: 548-52.
6. Welch HG, Albertsen PC. Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005. J Natl Cancer Inst 2009;101:1325-9.
7. Welch HG, Fisher ES, Gottlieb DJ, Barry MJ. Detection of prostate cancer via biopsy in the Medicare-SEER population during the PSA era. J Natl Cancer Inst 2007;99:1395-400.
8. Kryvenko ON, Jankowski M, Chitale DA, Tang D, Rundle A, Trudeau S, et al. Inflammation and preneoplastic lesions in benign prostate as risk factors for prostate cancer. Mod Pathol 2012;25:1023-32.
9. Tang D, Kryvenko ON, Wang Y, Jankowski M, Trudeau S, Rundle A, et al. Elevated polycyclic aromatic hydrocarbon-DNA adducts in benign prostate and risk of prostate cancer in African Americans. Carcinogenesis 2013;34:113-20.
10. MacInnis RJ, English DR. Body size and composition and prostate cancer risk: Systematic review and meta-regression analysis. Cancer Causes Control 2006;17:989-1003.
11. Freedland SJ, Giovannucci E, Platz EA. Are findings from studies of obesity and prostate cancer really in conflict? Cancer Causes Control 2006;17:5-9.
12. Freedland SJ, Platz EA. Obesity and prostate cancer: Making sense out of apparently conflicting data. Epidemiol Rev 2007;29: 88-97.
13. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003;348:1625-38.
14. Rodriguez C, Patel AV, Calle EE, Jacobs EJ, Chao A, Thun MJ. Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States. Cancer Epidemiol Biomarkers Prev 2001;10:345-53.
15. Discacciati A, Orsini N, Wolk A. Body mass index and incidence of localized and advanced prostate cancer-A dose-response meta-analysis of prospective studies. Ann Oncol 2012;23:1665-71.
16. Fowke JH, Signorello LB, UnderwoodWIII, Ukoli FA, Blot WJ. Obesity and prostate cancer screening among African-American and Caucasian men. Prostate 2006;66:1371-80.
17. Banez LL, Hamilton RJ, Partin AW, Vollmer RT, Sun L, Rodriguez C, et al. Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer. JAMA 2007;298:2275-80.
18. Rundle A, Neugut AI. Obesity and screening PSA levels among men undergoing an annual physical exam. Prostate 2008;68:373-80.
19. Wallner LP, Morgenstern H, McGree ME, Jacobson DJ, St Sauver JL, Jacobsen SJ, et al. The effects of body mass index on changes in prostate-specific antigen levels and prostate volume over 15 years of follow-up: Implications for prostate cancer detection. Cancer Epidemiol Biomarkers Prev 2011;20:501-8.
20. Price MM, Hamilton RJ, Robertson CN, Butts MC, Freedland SJ. Body mass index, prostate-specific antigen, and digital rectal examination findings among participants in a prostate cancer screening clinic. Urology 2008;71:787-91.
21. Fontaine K, Heo M, Allison D. Obesity and prostate cancer screening in the USA. Public Health 2005;119:694-8.
22. Sobal J, Stunkard AJ. Socioeconomic status and obesity: A review of the literature. Psychol Bull 1989;105:260-75.
23. Ball K, Crawford D. Socioeconomic status and weight change in adults: A review. Soc Sci Med 2005;60:1987-2010.
24. Rundle A, Field S, Park Y, Freeman L, Weiss CC, Neckerman K. Personal and neighborhood socioeconomic status and indices of neighborhood walk-ability predict body mass index in New York City. Soc Sci Med 2008;67:1951-8.
25. Greenlee RT, Howe HL. County-level poverty and distant stage cancer in the United States. Cancer Causes Control 2009;20:989-1000.
26. Collins S, Robertson R, Garber T, Doty M. Tracking trends in health care system performance: The income divide in health care: How the Affordable Care Act will help restore fairness to the U.S. health system. Issue Brief (The Commonwealth Fund) 2012;3:1-24.
27. Gong Z, Neuhouser ML, Goodman PJ, Albanes D, Chi C, Hsing AW, et al. Obesity, diabetes, and risk of prostate cancer: Results from the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev 2006;15:1977-83.
28. Freedland SJ, Terris MK, Platz EA, Presti JC Jr. Body mass index as a predictor of prostate cancer: Development versus detection on biopsy. Urology 2005;66:108-13.
29. Kim JM, Song PH, Kim HT, Moon KH. Effect of obesity on prostatespecific antigen, prostate volume, and international prostate symptom score in patients with benign prostatic hyperplasia. Korean J Urol 2011;52:401-5.
30. Schatzkin A, Freedman LS, Dawsey SM, Lanza E. Interpreting precursor studies: What polyp trials tell us about large-bowel cancer. J Natl Cancer Inst 1994;86:1053-7.
31. Shamliyan T, Wang SY, Virnig BA, Tuttle TM, Kane RL. Association between patient and tumor characteristics with clinical outcomes in women with ductal carcinoma in situ. J Natl Cancer Inst Monogr 2010;2010:121-9.
32. Virnig BA, Wang SY, Shamilyan T, Kane RL, Tuttle TM. Ductal carcinoma in situ: Risk factors and impact of screening. J Natl Cancer Inst Monogr 2010;2010:113-6.
33. Kamat P, Wen S, Morris J, Anandasabapathy S. Exploring the association between elevated body mass index and Barrett's esophagus: A systematic review and meta-analysis. Ann Thorac Surg 2009;87: 655-62.
34. Morois S, Mesrine S, Josset M, Clavel-Chapelon F, Boutron-Ruault MC. Anthropometric factors in adulthood and risk of colorectal adenomas: The French E3N-EPIC prospective cohort. Am J Epidemiol 2010;172:1166-80.
35. Fowke JH, Motley SS, Wills M, Cookson MS, Concepcion RS, Eckstein CW, et al. Prostate volume modifies the association between obesity and prostate cancer or high-grade prostatic intraepithelial neoplasia. Cancer Causes Control 2007;18:375-84.
36. Beebe-Dimmer JL, Nock NL, Neslund-Dudas C, Rundle A, Bock CH, Tang D, et al. Racial differences in risk of prostate cancer associated with metabolic syndrome. Urology 2009;74:185-90.
37. Freedland SJ, Platz EA, Presti JC Jr, Aronson WJ, Amling CL, Kane CJ, et al. Obesity, serum prostate specific antigen and prostate size: Implications for prostate cancer detection. J Urol 2006;175: 500-4.
38. Kant P, Hull MA. Excess body weight and obesity-the link with gastrointestinal and hepatobiliary cancer. Nat Rev Gastroenterol Hepatol 2011;8:224-38.
39. Ryan AM, Duong M, Healy L, Ryan SA, Parekh N, Reynolds JV, et al. Obesity, metabolic syndrome and esophageal adenocarcinoma: Epidemiology, etiology and new targets. Cancer Epidemiol 2011;35: 309-19.